Effect of immunoglobin-like transcript 7 cross-linking on plasmacytoid dendritic cells differentiation into antigen-presenting cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Tavano, Barbara ^a   Boasso, Adriano ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 BETA7 INTEGRIN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; IMMUNOGLOBULIN LIKE TRANSCRIPT 7; INTERFERON; MEMBRANE PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SYNTHESIS; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; INNATE IMMUNITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; UPREGULATION;

ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, CCR7; RECEPTORS, IMMUNOLOGIC; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84897802023     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089414     Document Type: Article

References (36)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811. 18/1/767 [pii];10.1146/annurev.immunol.18.1.767 [doi].
2. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226. ni1141 [pii];10.1038/ni1141 [doi].
3. Reis e Sousa (2004) Toll-like receptors and dendritic cells: for whom the bug tolls. Semin Immunol 16: 27-34. S1044532303000976 [pii].
4. Boasso A, Shearer GM, Chougnet C (2009) Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? J Intern Med 265: 78-96. JIM2043 [pii];10.1111/j.1365-2796.2008.02043.x [doi].
5. Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P (2007) Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 8: 209-216. (Pubitemid 46628286)
6. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774. 10.1038/nri1457 [doi];nri1457 [pii].
7. Kudo Y, Boyd CA (2000) Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim Biophys Acta 1500: 119-124. S0925-4439(99)00096-4 [pii].
8. Sakurai K, Zou JP, Tschetter JR, Ward JM, Shearer GM (2002) Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129: 186-196. S0165572802001765 [pii].
9. Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF (2003) Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125: 1762-1773. S0016508503015130 [pii].
10. Swanson KA, Zheng Y, Heidler KM, Mizobuchi T, Wilkes DS (2004) CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30: 311-318. 10.1165/rcmb.2003-0268OC [doi];2003-0268OC [pii].
11. Jegalian AG, Facchetti F, Jaffe ES (2009) Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol 16: 392-404. 10.1097/PAP.0b013e3181bb6bc2 [doi];00125480-200911000-00003 [pii].
12. Boasso A, Shearer GM (2008) Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 126: 235-242. S1521-6616(07)01329-0 [pii];10.1016/j.clim.2007.08.015 [doi].
13. Munn DH, Mellor AL (2004) IDO and tolerance to tumors. Trends Mol Med 10: 15-18. S147149140300248X [pii].
14. Baenziger S, Heikenwalder M, Johansen P, Schlaepfer E, Hofer U et al. (2009) Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113: 377-388. blood-2008-04-151712 [pii];10.1182/blood-2008-04-151712 [doi].
15. Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H et al. (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10: 187-192. 10.1038/nm987 [doi];nm987 [pii].
16. Colonna M, Nakajima H, Cella M (2000) A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin Immunol 12: 121-127. 10.1006/smim.2000.0214 [doi];S1044-5323(00) 90214-8 [pii].
17. Ju XS, Hacker C, Scherer B, Redecke V, Berger T et al. (2004) Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 331: 159-164. 10.1016/j.gene.2004.02.018 [doi];S0378111904001052 [pii].
18. Cao W, Bover L (2010) Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev 234: 163-176. IMR867 [pii];10.1111/j.0105-2896.2009.00867.x [doi].
19. Cao W, Rosen DB, Ito T, Bover L, Bao M et al. (2006) Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 203: 1399-1405. jem.20052454 [pii];10.1084/jem.20052454 [doi].
20. Cao W, Bover L, Cho M, Wen X, Hanabuchi S et al. (2009) Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 206: 1603-1614. jem.20090547 [pii];10.1084/jem.20090547 [doi].
21. Tavano B, Galao RP, Graham DR, Neil SJ, Aquino VN et al. (2013) Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes. J Immunol 190: 2622-2630. jimmunol. 1202391 [pii];10.4049/jimmunol.1202391 [doi].
22. Gorfu G, Rivera-Nieves J, Ley K (2009) Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 9: 836-850.
23. Braun A, Worbs T, Moschovakis GL, Halle S, Hoffmann K et al. (2011) Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol 12: 879-887. ni.2085 [pii];10.1038/ni.2085 [doi].
24. Boasso A, Shearer GM (2008) Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 126: 235-242. S1521-6616(07)01329-0 [pii];10.1016/j.clim.2007.08.015 [doi].
25. Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M et al. (2003) Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 170: 4465-4474. (Pubitemid 36519951)
26. Kubo-Murai M, Hazeki K, Nigorikawa K, Omoto T, Inoue N et al. (2008) IRAK-4-dependent degradation of IRAK-1 is a negative feedback signal for TLR-mediated NF-kappaB activation. J Biochem 143: 295-302. mvm234 [pii];10.1093/jb/mvm234 [doi].
27. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23-33. S0092-8674(00)80059-8 [pii].
28. Seth S, Oberdorfer L, Hyde R, Hoff K, Thies V et al. (2011) CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J Immunol 186: 3364-3372. jimmunol.1002598 [pii];10.4049/jimmunol.1002598 [doi].
29. de la Rosa G, Longo N, Rodriguez-Fernandez JL, Puig-Kroger A, Pineda A et al. (2003) Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J Leukoc Biol 73: 639-649. (Pubitemid 38040477)
30. Penna G, Sozzani S, Adorini L (2001) Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 167: 1862-1866. (Pubitemid 32747488)
31. Krug A, Uppaluri R, Facchetti F, Dorner BG, Sheehan KC et al. (2002) IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 169: 6079-6083. (Pubitemid 36903450)
32. Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de BO et al. (2003) The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 198: 823-830. 10.1084/jem.20020437 [doi];-jem.20020437 [pii].
33. Kohrgruber N, Groger M, Meraner P, Kriehuber E, Petzelbauer P et al. (2004) Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 173: 6592-6602. 173/11/6592 [pii].
34. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z et al. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-288. 10.1016/j.immuni.2004.06.014 [doi];S1074761304002018 [pii].
35. Schmid MA, Takizawa H, Baumjohann DR, Saito Y, Manz MG (2011) Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 118: 4829-4840. blood-2011-03-344960 [pii];10.1182/blood-2011-03-344960 [doi].
36. O'Sullivan B, Thomas R (2003) CD40 and dendritic cell function. Crit Rev Immunol 23: 83-107. (Pubitemid 36875475)